IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Johnson & Johnson Innovation - Jjdc, Inc.

Portfolio Profile

CIK: 0000924020 | NEW BRUNSWICK, NJ

$373.0M
AUM
21
Positions
99.99%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Arrowhead Pharmaceuticals(ARWR)3,260,869$270.1M72.40%
2Cvrx, Inc.(CVRX)3,495,575$97.9M26.24%
3Aldeyra Therapeutics, Inc.(ALDX)394,834$4.5M1.20%
4Fate Therapeutics, Inc.(FATE)3,379,064$293.3K0.08%
5Protagonist Therapeutics Inc.(PTGX)2,449,183$109.9K0.03%
6Legend Biotech Corporation(LEGN)1,629,173$66.9K0.02%
7Meiragtx Holdings PLC(MGTX)2,898,550$44.9K0.01%
8Fusion Pharmaceuticals Inc.3,670,516$29.7K0.01%
9VOR Biopharma, Inc.1,074,658$20.0K0.01%
10Biomx Inc.2,133,402$11.6K0.00%

Sector Allocation

Latest filing, equity positions only

Healthcare99.96% · $372.9M
Unclassified0.04% · $134.1K

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare99.93%99.96%+0.03%
Unclassified0.07%0.04%-0.03%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$210.4M | 11 pos.
$95.4M | 12 pos.
$143.7M | 15 pos.
$145.2M | 16 pos.
$254.8M | 15 pos.
$221.5M | 17 pos.
Cap SizePrev %Curr %Change
Mid Cap97.68%72.45%-25.23%
Micro Cap2.24%27.52%+25.28%
Unclassified0.07%0.04%-0.03%
Small Cap0%0%0%
$373.0M | 21 pos.
Q4
19
Q1
20
Q2
20
Q3
20
Q4
20
Q1
21
Q2
21

Recent Activity

Quarter-over-quarter position changes

4
New
0
Closed
0
Increased
1
Decreased
16
Unchanged